SBIR/STTR Research Award
Rumbo: An Integrated Mobile and Web-Based Application to Overcome Barriers to Receive Substance Use Disorder (SUD) Treatment and Improve Outcomes for Spanish-Speaking, Hispanic and Latinx Individuals
Award amount
$275,743Program and phase
SBIR · Phase IAward year
2023Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- VOLVER HEALTH LLC
- Proposal award date
- 2023-06-01
- Contract end date
- 2023-12-31
- UEI
- ZFTTTMJ9RA93
- Solicitation number
- PA21-260
- Topic code
- NIDA
Research abstract
PROJECT SUMMARY/ABSTRACT
Substance use is a significant problem among Latinx and Hispanics due to the
disproportionate number of physical harms and negative consequences associated with
substance use relative to other racial/ethnic groups. However, Hispanics are less likely
than other racial/ethnic groups to seek treatment for substance use, regardless of the
substance(s) they use, and only 75% as likely to complete treatment for heroin as White
individuals. Treatment navigators, like patient portals, were originally intended to offset
disparities in access to treatment and health care. Unfortunately, initial uptake of these
patient-facing eHealth tools was found among white, educated, middle-class individuals
already actively engaged in their own health care and not by socially disadvantaged and
marginalized minority populations, as though the structural barriers to care that exist in
the treatment system were carried forward in the solution meant to overcome them.
Nonetheless, there are still many who believe that eHealth has the potential to help
marginalized people seeking care to surmount these barriers. Research over the last
decade has revealed that adoption of eHealth among marginalized populations is
influenced by factors such as health information-seeking behaviors, level of eHealth
literacy, and technology acceptance, so we have designed a treatment navigator for
Hispanics that is informed by these findings. “Rumbo” is an easily shared bi-lingual
integrated web and mobile application that helps both Spanish-speaking and non-Spanish-
speaking Hispanic individuals with substance use challenges find and access treatment
services and related supportive resources. The proposed innovation stands out from other
eHealth tools by leveraging the collective efficacy of the Hispanic community to overcome
barriers and support individuals’ self-efficacy for engaging the treatment system. Rumbo’s
simple, user-centered design provides less-acculturated Hispanic individuals with a
culturally appropriate tool to understand their needs within the complex US treatment
system. In this Phase I project we will develop the app’s content and functions with a
community-based, user-centered, iterative design process that will inform the content and
functions of the app. We will gather key stakeholders in the Bernalillo County treatment
system (the most populous area in New Mexico and 50% Hispanic) to develop a database of
available, culturally appropriate resources, and to support both project recruitment and
dissemination of the initial version of the app. Once completed, we will evaluate Rumbo’s
acceptability and capability as a treatment navigator in a naturalistic implementation
study, as well as how it is shared among users, and whether the individuals who use
Rumbo subsequently have increased confidence in accessing services.
Technology keywords
Not reported
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Wearable Wireless Respiratory Monitoring System that Detects and Predicts Opioid Induced Respiratory Depression
- Building and testing the Life Enhancement and Advocacy Programming digital training tool (LEAPLink) to better serve people with lived experience of homelessness and substance use disorder
- A digital intervention to decrease self-stigma among pregnant and postpartum women with opioid use disorder
- Development of medication for the treatment of respiratory depression due to opioid (prescribed or illicit) overdose/multidrug (polysubstance) overdose in a hospital or community setting.
- Creation and Validation of the Dose-Opioid-Source Evaluation tool (DOSE) - a Robust Opioid Use Clinical Outcome Assessment for Qualification as an FDA Medical Device Development Tool (MDDT)